Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/viking-therapeutics-to-report-financial-results-for-first-quarter-2024-on-april-24-2024-302119720.html
https://www.fiercebiotech.com/biotech/biotech-naming-trends-bypass-buzzwords-and-business-speak-build-whimsical-memorable-brands
https://www.reuters.com/business/healthcare-pharmaceuticals/viking-therapeutics-says-its-experimental-tablet-reduced-weight-early-stage-2024-03-26/
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-results-from-phase-1-clinical-trial-of-oral-tablet-formulation-of-dual-glp-1gip-receptor-agonist-vk2735-302098869.html
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-closing-of-public-offering-of-common-stock-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-302078953.html
https://za.investing.com/news/truist-raises-viking-therapeutics-stock-target-to-120-on-glp1-profile-93CH-3029247
https://www.biopharmadive.com/news/viking-obesity-drug-study-results-zepbound-wegovy/708622/
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-pricing-of-550-million-public-offering-of-common-stock-302074989.html
https://www.prnewswire.com/news-releases/viking-therapeutics-announces-proposed-public-offering-of-common-stock-302073312.html
https://www.prnewswire.com/news-releases/viking-therapeutics-reports-fourth-quarter-and-year-end-2023-financial-results-and-provides-corporate-update-302056675.html